CVS Health has made significant changes to its leadership as the company faces ongoing challenges, including a notable decline in stock value. Karen Lynch has been ousted from her position as CEO, with David Joyner, the former head of Caremark, stepping in as her replacement. This leadership shift comes alongside a series of layoffs and a lowered earnings outlook, as CVS Health grapples with poor stock performance and pressure from investors. Joyner has issued a plea for support from employees during this transition, while CVS shares fell sharply following the announcement. The company is now under scrutiny as it seeks to navigate these tumultuous times and reverse its fortunes.